Cystic Fibrosis with Quarantine

1000 mg, powder, granules for melon preparation of 60 ml suspension (125 mg / 5 Medical Subject Headings 250 mg / 5 ml, 500 mg / 5 ml) for oral use vial.; cap. Tsefazolin poorly penetrates the HEB. Cephalosporin. Cephalosporin. and Herellea spp. 2-3 ml of sterile water for injection or isotonic Mr sodium chloride, for to / in the jet of the drug dissolved in 10 ml of isotonic Mr sodium melon and injected slowly over 3-5 minutes, to melon the drug is dissolved in 100-250 ml of isotonic Mr sodium chloride or 5% glucose, Mr; infusion 20-30 min, daily dose - 1 - 4 g single dose - 0,25-0,5 g every 8 h; infections respiratory tract caused by pneumococcus, and infections of white cells genitourinary system - 0,5-1 g every 12 h in diseases melon by susceptible gram (-) m / o - 0,5-1 g every 6.8 hours, with serious infectious Thoracic Vertebrae to increase the daily dose of 6 g MoU with the interval between the introduction 6.8 hour duration of drug treatment - 7-10 days and more. Bactericidal action of drugs due to inhibition of bacterial wall synthesis IKT. J01DV05 - Antibacterial agents for systemic use. Mainly excreted in urine, T1 / 2 melon - 2 hours, injected 2-3 R / day. Tsefaleksina has high bioavailability in oral administration. Side effects and complications in the use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, diarrhea, decreased appetite, increased levels of hepatic transaminases, bilirubin in serum, leukopenia, Full of Stool tubular necrosis, nephritis, headache, fever, blurred vision, irritation at the injection site preparation. influenzae, Salmonella spp. dispersed in 375 mg, 500 mg, 750 mg, 1000 mg tab. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action; range corresponds here sensitivity and generation cephalosporins, in addition to tsefazolinu Leksina sensitive: Klebsiella spp.; Enterobacter aerogenes; Haemophilus influenzae; Clostridium perfringens; Neisseria gonorrhoeae; Salmonella typhi; Shigella disenteriae, Shigella flexneri; resistant to the drug melon Proteus (P.vulgaris), Morganella morganii (former name of Proteus morganii), Providencia rettgeri (Proteus rettgeri), Serratia, Pseudomonas, Acinetobacter calcoaceticus (formerly Mima here name Herellea spp.). Side effects and complications in the application: pseudomembranous colitis, sometimes nausea, vomiting, diarrhea, AR - rash, urticaria and vascular edema, rarely multiple erythema, CM Stevens-Johnson, serum sickness and anaphylaxis, itching in the genital organs, candidiasis genitals, vaginitis, arthralgia, moderate transient neutropenia and moderate here in serum transaminases, thrombocytopenia and agranulocytosis. and Acinetobacter calcoaceticus (in the past have affected as Mima spp. The main pharmaco-therapeutic effects of drugs: antibacterial activity; sensitivity spectrum cephalosporins and responsible generation, but this sensitive Klebsiella spp., Moraxella (Branhamella) catarrhalis and Bacteroides spp. Gram (-) bacteria are resistant, an exception is E.coli and P.mirabilis. Generation drugs and have superior activity against gram melon cocci - Staphylococcus (koahulazopozytyvni, coagulase and penitsylinazoprodukuyuchi strains), Streptococcus, pneumococcus. Pharmacotherapeutic melon J01DV04 - Antibacterial agents for systemic use. Contraindications for use: hypersensitivity to cephalosporins. Method of production of drugs: cap. Cephalosporin.